REDDAH MEDICAL: what changed
What changed
REDDAH MEDICAL
NACE 86.210, General medical practice
filed annual accounts (NBB)
Net result for the year
€8,228
2024 · €27,279-€19,050
Equity
€40,348
2024 · €32,119+€8,228
Cash
€45,235
2024 · €37,850+€7,385
Balance sheet total
€45,544
2024 · €38,832+€6,712
Largest movements
Assets
- Cash +€7,385
up €7,385 (+19.5%), from €37,850 to €45,235
mainly Net result for the year (+€8,228) and Depreciation (+€333)
Equity and liabilities
- Profit (loss) carried forward +€8,228
up €8,228 (+25.7%), from €32,019 to €40,248
- Other debts -€963
down €963 (-18.1%), from €5,323 to €4,360
- Trade debts -€764
down €764 (-55.0%), from €1,389 to €625
Income statement
- Gross operating margin -€18,903
down €18,903 (-59.0%), from €32,041 to €13,138
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€27,279
Gross operating margin
-€18,903
Other operating charges
-€18
Financial income
-€0
Financial charges
-€63
Taxes
-€66
Result 2025
€8,228
lowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€7,385
Investment
€0
Financing
€0
Cash 2024
€37,850
From operations (derived)
+€7,385
Net result for the year
+€8,228
Depreciation
+€333
Receivables within one year
+€239
Deferred charges and accrued income
+€101
Trade debts
-€764
Tax, wage and social debts
+€211
Other debts
-€963
Cash 2025
€45,235
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €38,832 | €45,544 | +€6,712 | +17.3% |
| Fixed assets | 21/28 | €444 | €111 | -€333 | -75.0% |
| Tangible fixed assets | 22/27 | €444 | €111 | -€333 | -75.0% |
| Furniture and vehicles | 24 | €444 | €111 | -€333 | -75.0% |
| Current assets | 29/58 | €38,388 | €45,433 | +€7,045 | +18.4% |
| Amounts receivable within one year | 40/41 | €239 | - | -€239 | |
| Other amounts receivable | 41 | €239 | - | -€239 | |
| Cash at bank and in hand | 54/58 | €37,850 | €45,235 | +€7,385 | +19.5% |
| Deferred charges and accrued income | 490/1 | €299 | €198 | -€101 | -33.7% |
| Total equity and liabilities | 10/49 | €38,832 | €45,544 | +€6,712 | +17.3% |
| Equity | 10/15 | €32,119 | €40,348 | +€8,228 | +25.6% |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Profit (loss) carried forward | 14 | €32,019 | €40,248 | +€8,228 | +25.7% |
| Amounts payable | 17/49 | €6,712 | €5,196 | -€1,516 | -22.6% |
| Amounts payable within one year | 42/48 | €6,712 | €5,196 | -€1,516 | -22.6% |
| Trade debts | 44 | €1,389 | €625 | -€764 | -55.0% |
| Suppliers | 440/4 | €1,389 | €625 | -€764 | -55.0% |
| Taxes, remuneration and social security | 45 | - | €211 | +€211 | |
| Taxes | 450/3 | - | €211 | +€211 | |
| Other amounts payable | 47/48 | €5,323 | €4,360 | -€963 | -18.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €333 | €333 | = | 0.0% |
| Other operating charges | 640/8 | €564 | €582 | +€18 | +3.3% |
| Gross operating margin | 9900 | €32,041 | €13,138 | -€18,903 | -59.0% |
| Operating profit (loss) | 9901 | €31,144 | €12,223 | -€18,921 | -60.8% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €482 | €545 | +€63 | +13.0% |
| Recurring financial charges | 65 | €482 | €545 | +€63 | +13.0% |
| Profit (loss) for the period before taxes | 9903 | €30,662 | €11,678 | -€18,984 | -61.9% |
| Income taxes | 67/77 | €3,383 | €3,449 | +€66 | +2.0% |
| Profit (loss) for the period | 9904 | €27,279 | €8,228 | -€19,050 | -69.8% |
| Profit (loss) for the period to be appropriated | 9905 | €27,279 | €8,228 | -€19,050 | -69.8% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.